Learn 8 tips for choosing the perfect genomic assay for your clinical trial

Genomic Assays for clinical developmentFinding the optimal genomic assay for your clinical development project’s requirements results in a smoother, more informed and efficient process, while the wrong assay – one that is less efficient or one that is not fit-for-purpose – leads to wasted time and money, and can delay delivery of important medications to waiting patients. 

In this complimentary insight brief, ensure your clinical trial success by learning top tips for choosing the perfect genomic assay for your development project so that the right drugs get to the right patients, on time.

From whole genome to focused set gene expression profiling and genotyping assays along with DNA and RNA sequencing services, sequence enrichment technologies and bioinformatics analysis expertise, we are a preferred partner that offers tailored solutions to support all product development needs.

Contact us today to learn how Q2 Solutions can help you identify the right genomic assay for your clinical development project.

About the authors:
Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics
Leveraging Genomics-Based Assays for Immuno-Oncology in Clinical Research

Molecular Medicine Tri-Conference 2017

New Opportunities for Immuno-oncology Clinical Development Programs through T cell/B cell Repertoire Profiling

Immune repertoire profiling provides better outcomes for immuno-oncology development programs

Companion Diagnostic Development: Current trends and recommendations

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Read More